Guidelines, Position Statements, Evidence Assessments and Consensus Opinions

2024

Andrew C. Charles MD, Kathleen B. Digre MD, Peter J. Goadsby MD, PhD, Matthew S. Robbins MD, Andrew Hershey MD, PhD, The American Headache Society. (2024) Calcitonin gene-related paptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update.

https://headachejournal.onlinelibrary.wiley.com/doi/full/10.1111/head.14692

2021

Jessica Ailani MD, Rebecca C. Burch MD, Matthew S. Robbins MD, on behalf of the Board of Directors of the American Headache Society. (2021) The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.

https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14153

2019

Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, Hershey AD, Licking N, Sowell M, Victorio MC, Gersz EM, Leininger E, Zanitsch H, Yonker M, Mack K. (2019) Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.

https://www.ncbi.nlm.nih.gov/pubmed/31413171

2018

Digre, K.., American Headache Society

https://onlinelibrary.wiley.com/doi/10.1111/head.13456

2016

https://onlinelibrary.wiley.com/doi/10.1111/head.12870/abstract

Robbins MS, Starling AJ, Pringsheim TM, Becker WJ, Schwedt TJ. Treatment of Cluster Headache: The American Headache Society Evidence-Based Guidelines. Headache. 2016 Jul;56(7):1093-106. doi: 10.1111/head.12866.

https://onlinelibrary.wiley.com/doi/10.1111/head.12866/abstract

Orr, S. L., Friedman, B. W., Christie, S., Minen, M. T., Bamford, C., Kelley, N. E. and Tepper, D. (2016), Management of Adults With Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies. Headache: The Journal of Head and Face Pain, 56: 911–940. doi:10.1111/head.12835

https://onlinelibrary.wiley.com/doi/10.1111/head.12835/abstract

2015

Marmura MJ1, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. Headache. 2015 Jan;55(1):3-20. doi: 10.1111/head.12499.

https://onlinelibrary.wiley.com/doi/10.1111/head.12499/abstract

2013

Loder, E., Weizenbaum, E., Frishberg, B., Silberstein, S. and American Headache Society Choosing Wisely Task Force (2013), Choosing Wisely in Headache Medicine: The American Headache Society’s List of Five Things Physicians and Patients Should Question. Headache: The Journal of Head and Face Pain, 53: 1651–1659. doi:10.1111/head.12233

https://onlinelibrary.wiley.com/doi/10.1111/head.12233/full

2012

Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012 Jun;52(6):930-45. doi: 10.1111/j.1526-4610.2012.02185.x.

https://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2012.02185.x/abstract

2010

Evans, R. W., Tepper, S. J., Shapiro, R. E., Sun-Edelstein, C. and Tietjen, G. E. (2010), The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper. Headache: The Journal of Head and Face Pain, 50: 1089–1099. doi:10.1111/j.1526-4610.2010.01691.x

https://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2010.01691.x/full

2005

Penzien, D. B., Andrasik, F., Freidenberg, B. M., Houle, T. T., Lake, A. E., Lipchik, G. L., Holroyd, K. A., Lipton, R. B., McCrory, D. C., Nash, J. M., Nicholson, R. A., Powers, S. W., Rains, J. C. and Wittrock, D. A. (2005), Guidelines for Trials of Behavioral Treatments for Recurrent Headache, First Edition: American Headache Society Behavioral Clinical Trials Workgroup. Headache: The Journal of Head and Face Pain, 45: S110–S132. doi:10.1111/j.1526-4610.2005.4502004.x

https://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2005.4502004.x/abstract

2004

Dodick, D., Lipton, R. B., Martin, V., Papademetriou, V., Rosamond, W., MaassenVanDenBrink, A., Loutfi, H., Welch, K.Michael., Goadsby, P. J., Hahn, S., Hutchinson, S., Matchar, D., Silberstein, S., Smith, T. R., Purdy, R. A., Saiers, J. and The Triptan Cardiovascular Safety Expert Panel (2004), Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT1B/1D Agonists) in the Acute Treatment of Migraine. Headache: The Journal of Head and Face Pain, 44: 414–425. doi:10.1111/j.1526-4610.2004.04078.x

https://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2004.04078.x/abstract